Kinetic analysis and design of experiments to identify the catalytic mechanism of the monocarboxylate transporter isoforms 4 and 1.
Transport of lactate, pyruvate, and other monocarboxylates across the sarcolemma of skeletal and cardiac myocytes occurs via passive diffusion and by monocarboxylate transporter (MCT) mediated transport. The flux of lactate and protons through the MCT plays an important role in muscle energy metabolism during rest and exercise and in pH regulation during exercise. The MCT isoforms 1 and 4 are the major isoforms of this transporter in skeletal and cardiac muscle. The current consensus on the mechanism of these transporters, based on experimental measurements of labeled lactate fluxes, is that monocarboxylate-proton symport occurs via a rapid-equilibrium ordered mechanism with proton binding followed by monocarboxylate binding. This study tests ordered and random mechanisms by fitting experimental measurements of tracer exchange fluxes from MCT1 and MCT4 isoforms to theoretical predictions derived using relationships between one-way fluxes and thermodynamic forces. Analysis shows that: 1), the available kinetic data are insufficient to distinguish between a rapid-equilibrium ordered and a rapid-equilibrium random-binding model for MCT4; 2), MCT1 has a higher affinity to lactate than does MCT4; 3), the theoretical conditions for the so-called trans-acceleration phenomenon (e.g., increased tracer efflux from a vesicle caused by increased substrate concentration outside the vesicle) do not necessarily require the rate constant for the lactate and proton bound transporter to reorient across the membrane to be higher than that for the unbound transporter; and finally, 4), based on model analysis, additional experiments are proposed to be able to distinguish between ordered and random-binding mechanisms.
Biotechnology and Bioengineering Center, Department of Physiology, Medical College of Wisconsin, Milwaukee, USA.
Kalyan C
KC
Vinnakota
Daniel A
DA
Beard
D000818:Animals; D001692:Biological Transport; D007700:Kinetics; D007773:Lactates / Q000378:metabolism*; D026901:Membrane Transport Proteins / Q000378:metabolism; D056004:Molecular Dynamics Simulation; D027501:Monocarboxylic Acid Transporters / Q000378:metabolism*; D009124:Muscle Proteins / Q000378:metabolism*; D009865:Oocytes / Q000378:metabolism; D020033:Protein Isoforms / Q000378:metabolism; D011522:Protons; D012508:Sarcolemma / Q000378:metabolism; D014981:Xenopus / Q000378:metabolism
D007773:Lactates; D026901:Membrane Transport Proteins; D027501:Monocarboxylic Acid Transporters; D009124:Muscle Proteins; D020033:Protein Isoforms; D011522:Protons
Biotechnol Bioeng. 1997 Jul 5;55(1):101-17
18636449
Biochim Biophys Acta. 1996 Aug 14;1283(1):106-10
8765101
Biochim Biophys Acta. 1995 Mar 16;1265(2-3):127-32
7696341
J Biol Chem. 1998 Jun 26;273(26):15920-6
9632638
Biochem J. 1999 Oct 15;343 Pt 2:281-99
10510291
Physiol Rev. 1997 Apr;77(2):321-58
9114817
Biochim Biophys Acta. 1991 May 31;1065(1):15-20
2043648
Am J Physiol. 1993 Apr;264(4 Pt 1):C761-82
8476015
Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E1067-77
10827010
Acta Physiol Scand. 1996 Mar;156(3):369-74
8729697
J Physiol. 1999 Jun 15;517 ( Pt 3):633-42
10358105
Biochem J. 1998 Jul 1;333 ( Pt 1):167-74
9639576
J Physiol. 2000 Dec 1;529 Pt 2:285-93
11101640
PLoS One. 2007 Jan 03;2(1):e144
17206279
Am J Physiol. 1982 Sep;243(3):R271-80
7114288
Eur J Appl Physiol. 2001 Nov;86(1):6-11
11820324
Biochem J. 2000 Aug 15;350 Pt 1:219-27
10926847